Drug Safety / Pharmacovigilance Officer salary analysis
Full guide to earning potential, growth path, and market demand in 2026.
Salary progression
Estimated annual compensation based on experience level
Growth Outlook
Strong — CDSCO's 2011 Pharmacovigilance Programme and updated New Drugs and Clinical Trials Rules (2019) mandate in-house PV systems at all Indian MAHs (Marketing Authorisation Holders), driving demand at domestic pharma. Global KPO volumes remain high as FDA/EMA regulatory expectations on ICSR timelines tighten post-COVID. Signal detection and aggregate reporting specialists are in shortage relative to demand even as entry-level ICSR processing faces some automation from NLP-assisted triage tools.
Market Demand
Senior pay (India)
₹35.0 LPA
Top of the band
India salary band
Fresher (0-2 yrs)
₹3.0 LPA
Mid (3-6 yrs)
₹7.0 LPA
Senior (7+ yrs)
₹35.0 LPA